Skip to main content

Table 2 Background characteristics of the matched cohorts

From: Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy

Variable

 

RFA (n = 62)

Repeat hepatic resection (n = 31)

χ2

P

v

Sex ratio (n)

Male:Female

41:21:00

18:13

1.36

0.244

1

Age(years)

≤ 60

30 (48.4)

14 (45.2)

0.206

0.65

1

> 60

32 (51.6)

17(54.8)

Primary tumor location (n%)

Colon

37 (59.7)

19 (61.3)

0.054

0.817

1

Rectum

25 (40.3)

12 (38.7)

Timing of liver metastases (n%)

Synchronous

47 (75.8)

22 (71.0)

0.59

0.442

1

Metachronous

15 (24.2)

9 (29.0)

Distribution of liver metastases (n%)

Unilobar

37 (59.7)

20 (64.5)

0.489

0.484

1

Bilobar

25 (40.3)

11 (35.5)

Preoperative chemotherapy (n%)

 

24 (38.7)

11 (35.5)

0.219

0.639

1

CEA (ng/ml)

≤ 10

39 (62.9)

20 (64.5)

0.055

0.814

1

> 10

23 (37.1)

11 (35.5)

Size of tumors (cm)

≤ 3

45 (72.6)

21 (67.7)

0.573

0.449

1

> 3

17 (27.4)

10 (32.3)

Number of metastatic tumors (n%)

Solitary

31 (50.0)

17 (54.8)

0.462

0.497

1

Multiple

31 (50.0)

14 (45.2)

Relapse time interval (months)

≤ 6

22 (35.5)

10 (32.2)

0.238

0.625

1

> 6

40 (64.5)

21 (67.7)

  1. Values in parentheses are percentages; RFA: radiofrequency ablation; CEA: carcinoembryonic antigen.